Ozempic, Wegovy, Mounjaro or Zepbound for PCOS: What the Research Shows
Ozempic, Wegovy, Mounjaro and Zepbound for PCOS: approval in Canada and the US, trial results on weight, periods and fertility, birth control, and user stories.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
No GLP-1 drug is approved for polycystic ovary syndrome (PCOS) in Canada or the US. Ozempic and Mounjaro are approved for type 2 diabetes, and Wegovy and Zepbound for chronic weight management, so a prescriber can use them for someone with PCOS who also fits one of those uses. The 2023 international PCOS guideline says GLP-1 drugs such as semaglutide could be considered, alongside lifestyle changes, to manage higher weight in adults with PCOS. Small trials suggest more weight loss, more regular periods and more natural pregnancies than metformin alone, but they are short and none is large or long-term. These drugs are not for use in pregnancy, and tirzepatide can make birth control pills less reliable. Not medical advice. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance. Last reviewed October 31, 2026.
Approval and coverage in Canada and the US
In Canada, provincial drug plans list Ozempic only under type 2 diabetes criteria, so PCOS on its own does not qualify (Ontario's rules, Quebec's rules). No province covers Wegovy for weight management (Wegovy coverage in Canada). Private plans set their own rules, so ask your insurer.
What the trials show
Both recent trials were small, open-label studies in Chinese women, and much of the benefit probably comes from the weight loss itself. The guideline also notes the high chance of weight regain after stopping and the lack of long-term safety data for PCOS.
| Study | Who was studied | What it found |
|---|---|---|
| Meta-analysis, 2023 | 11 randomized trials, 840 women with PCOS, GLP-1 drugs vs control treatment | More natural pregnancies (risk ratio 1.72) and more regular periods, better insulin resistance, BMI and waist size; only a slight drop in testosterone |
| Semaglutide + metformin, 2025 | 100 women with PCOS and higher weight, 16 weeks, open-label | Weight loss 6.1 kg vs 2.3 kg on metformin alone, lower testosterone, more periods returning; natural pregnancies over the next 24 weeks 35% vs 15% |
| Tirzepatide + metformin, 2026 | 60 women with PCOS and higher weight, 16 weeks, open-label | Weight loss 10.4 kg vs 1.7 kg on metformin alone, less visceral fat, more cycles returning and a higher pregnancy rate |
| PERIODS trial (recruiting) | About 198 women in Germany, tirzepatide vs placebo, double-blind, 72 weeks | First placebo-controlled tirzepatide trial for PCOS ovarian function; results not expected before 2028 |
Ozempic vs metformin and other PCOS treatments
Source: 2023 International Evidence-based Guideline for PCOS. Which option fits depends on whether the main goal is weight, periods, skin and hair, or pregnancy, and that is a decision for you and your clinician.
| Option | What the 2023 guideline says |
|---|---|
| Metformin | Should be considered in adults with PCOS and a BMI of 25 or more for weight and metabolic outcomes, including insulin resistance |
| Combined birth control pill | Could be recommended for irregular periods and unwanted hair growth |
| GLP-1 drugs (liraglutide, semaglutide) | Could be considered with lifestyle changes for higher weight in adults, with effective contraception and a discussion of side effects and long-term use |
| Lifestyle changes | The base for everyone, whatever else is used |
Birth control, fertility and "Ozempic babies"
- —The PCOS guideline says to use effective contraception while on a GLP-1 drug if pregnancy is possible, because safety data in pregnancy are lacking.
- —The Mounjaro and Zepbound labels say tirzepatide can make birth control pills less effective, and advise switching to a non-pill method or adding a barrier method for 4 weeks after starting and after each dose increase.
- —The US Ozempic and Wegovy labels say to stop semaglutide at least 2 months before a planned pregnancy.
- —In PCOS, periods and ovulation can come back as weight comes off, so fertility can rise sooner than expected. More detail: GLP-1 drugs, pregnancy and birth control.
What users report here
From live confessions (checked October 31, 2026). #686 started semaglutide and lost no weight for two months, but says their feet and joints felt less inflamed, then their ring got loose and their period came back after three or four years without one. They have PCOS. #893, 31 with PCOS and no regular period for three years, says that in month 4 on tirzepatide they had two periods back to back, then none, and then a positive pregnancy test; they say nobody told them tirzepatide can make the pill less reliable. Stories, not rates.
Related topics
related peptides:
in Canada:
community guides:
More confessions from the archive
Community Q&A
- Is Ozempic approved for PCOS?
- No. Ozempic is approved for type 2 diabetes in Canada and the US. No GLP-1 drug has a PCOS approval; prescribers sometimes use them for people with PCOS who also have type 2 diabetes or higher weight.
- Does Ozempic help PCOS?
- In small trials, semaglutide added to metformin led to more weight loss, more regular periods and more natural pregnancies than metformin alone. The trials were short and open-label, and no large long-term PCOS trial has been published.
- Does Zepbound or Mounjaro help PCOS?
- A small 16-week trial found more weight loss and more cycles returning with tirzepatide plus metformin than metformin alone. The first placebo-controlled tirzepatide PCOS trial (PERIODS) is still recruiting.
- Is Ozempic covered for PCOS in Canada?
- Not by provincial plans, which list Ozempic only under type 2 diabetes criteria. Some private plans set their own rules, so check with your insurer.
- Can Ozempic help you get pregnant with PCOS?
- Trials found more natural pregnancies after GLP-1 treatment, mostly linked to weight loss and returning ovulation. These drugs are not meant for use in pregnancy, so plan with your prescriber; the US semaglutide labels say to stop at least 2 months before a planned pregnancy.
- Is Ozempic or metformin better for PCOS?
- They do different jobs. The 2023 guideline recommends considering metformin for metabolic outcomes and GLP-1 drugs for higher weight, alongside lifestyle changes. Trials combining the two found more weight loss than metformin alone.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Last reviewed October 31, 2026. Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.